Phendimetrazine
Back to searchMolecule Structure
Scientific Name
Phendimetrazine
Description of the Drug
Phendimetrazine is a sympathomimetic amine used as adjunct therapy for the short term management of exogenous obesity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01579
http://www.drugbank.ca/drugs/DB01579
Brand Name(s)
Not Available
Company Owner(s)
Vitarine Pharmaceuticals Inc, Kv Pharmaceutical Co, Elite Laboratories Inc, Watson Laboratories Inc, Nexgen Pharma Inc, Numark Laboratories Inc, Mm Mast And Co, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Teva Pharmaceuticals Usa Inc, Wyeth Ayerst Laboratories
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL238 |
| Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL598950 | |||
| DrugBank | DB01579 | |||
| PubChem: Thomson Pharma | 15120810 | |||
| PubChem | 30487 | |||
| Nikkaji | J6.905A | |||
| DrugCentral | 2122 | |||
| rxnorm | BONTRIL | PHENDIMETRAZINE TARTRATE | MELFIAT | PHENDIMETRAZINE |
| KEGG Ligand | C07904 | |||
| ChEBI | 8059 | |||
| ZINC | ZINC000022010387 |
